“Hectic fever (sepsis) at its inception is difficult to recognize but easy to treat. Left untended, it becomes easy to recognize but difficult to treat.”
— Niccolo Machiavelli (1498)
I. GENERAL PRINCIPLES
A. Definitions.
1. Systemic inflammatory response syndrome (SIRS).
a. Clinical response to nonspecific injury, including trauma, burns, infection, pancreatitis, or alternative inflammatory insult.
b. Clinical components of SIRS (two elements required to define).
i. Temperature ≥38°C or ≤36°C.
ii. Heart rate ≥90 per minute.
iii. Respirations ≥20 per minute.
iv. Leukocyte count >12,000 or <4,000 or >10% bands.
v. PaCO2 < 32 mm Hg.
2. Sepsis.
a. Documented or suspected infection and evidence of clinical inflammatory response.
b. 1992 criteria—Two or more SIRS criteria with associated infection define sepsis.
c. 2001 criteria—Documented or suspected infection with some markers of inflammation (
Table 117-1).
3. Severe sepsis.
a. Sepsis with associated organ dysfunction or tissue hypoperfusion (
Table 117-2).
4. Septic shock.
a. Sepsis with refractory hypotension after appropriate fluid resuscitation.
b. Suggested appropriate resuscitation of at least 30 mL/kg crystalloid minimum to be considered refractory.
5. Multiple-organ dysfunction syndrome (MODS).
a. Disease spectrum in which one or more organ systems are unable to maintain homeostasis without support in an acutely ill patient.
b. MODS has many potential sources. Sepsis is one of the most common (
Table 117-3).
B. Epidemiology.
1. Severe sepsis represents 20% of all ICU admissions in the United States (US).
2. Severe sepsis is the number one cause of death in the non-coronary care ICU and the 10th leading cause of death in the US.
3. Severe sepsis has an estimated 28% to 50% mortality rate.
4. Septic shock has an estimated mortality of 60%.
5. MODS is a leading cause of death in the ICU. Depending on the number of organ systems involved, MODS can carry an 80% mortality rate.
II. PATHOPHISIOLOGY
A. Infection.
1. Sepsis is an overwhelming and complicated proinflammatory response to infection.
2. Inciting organisms have changed with time. Change is connected to drug resistance.
3. Gram-negative and gram-positive organisms are each separately linked to 25% of sepsis-related infections.
4. Mixed gram-negative and gram-positive infections account for about 15% of causative infections.
5. Fungi associated with 5% to 10% of infections.
B. Pathogen induction.
1. Inflammatory response starts with recognition of pathogen molecular components by receptors on cells of the innate immune system.
2. Innate immune cell members consist of neutrophils, macrophages, monocytes, basophils, eosinophils, natural killer cells, mast cells, dendritic cells, and platelets.
3. Pathogen-inducing components capable of triggering an immune response are numerous and include lipopolysaccharide (LPS) from gram-negative bacteria; lipoteichoic acid from gram-positive bacteria, and flagellin.
C. Toll-like receptors (TLRs).
1. TLRs are cell membrane proteins that exist to specifically recognize a variety of pathogen- and tissue damage-associated components.
2. TLRs are a key element to initiating the immune response. TLRs along with other proteins comprise a cadre known as pattern recognition receptors (PRRs).
3. Activation of TLRs leads to initiation of the inflammatory cascade. This includes activation of the critical transcription factor NF-κB. Ongoing response is variable and host dependent.
4. Key TLRs include TLR-2 and TLR-4.
D. Mediators of sepsis.
1. Activation of the inflammatory cascade precipitates the release and interaction of myriad important mediators.
2. These mediators encompass cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α(TNF-α).
3. High mobility group box-1 (HMGB-1) is a unique cytokine that can provoke a lethal proinflammatory response.
4. Additional mediators include platelet-activating factor (PAF), bradykinin, nitric oxide, and elements of the complement system.
E. End-organ consequences.
1. Sepsis-associated mediators contribute to end-organ damage. Damage elements include vasodilatation and altered perfusion, microvascular permeability and thrombosis, myocardial depression, mitochondrial dysfunction, maladaptive use of cellular nutrients, and cellular apoptosis.
III. DIAGNOSIS
Only gold members can continue reading.
Log In or
Register to continue
Related
Full access? Get Clinical Tree